Primary central nervous system lymphoma: Report of 32 cases and review of the literature

Clinical Neurology and Neurosurgery

Volumn 107, Issue 1, 2004, Pages 55-63

  Dubuisson, Annie ^a   Kaschten, Bruno ^a   Lénelle, Jacques ^a   Martin, Didier ^a   Robe, Pierre ^a   Fassotte, Marie France ^a   Rutten, Isabelle ^a   Deprez, Manuel ^b   Stevenaert, Achille ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Brain neoplasms; Chemotherapy; Primary central nervous system lymphoma; Radiation therapy; Stereotaxic biopsy

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; CORTICOSTEROID; CYTARABINE; DEXAMETHASONE; GADOLINIUM; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; BEHAVIOR DISORDER; BONE MARROW APLASIA; BRAIN RADIATION; BRAIN THIRD VENTRICLE; BRAIN VENTRICLE TUMOR; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM TUMOR; CEREBROSPINAL FLUID CYTOLOGY; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CRANIOTOMY; DIARRHEA; DRUG MEGADOSE; DRUG PENETRATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; LYMPHOMA; MALE; NAUSEA; NEUROLOGIC DISEASE; NEUROTOXICITY; POSTOPERATIVE COMPLICATION; REVIEW; STEREOTAXIC SURGERY; TUMOR BIOPSY;

EID: 9344246278     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2004.03.005     Document Type: Article

References (57)

1. Corn B.W., Marcus S.M., Topham A., Hauck W., Curran W.J. Will primary central nervous system lymphoma be the most frequent brain tumor diagnosed in the year 2000? Cancer. 79(12):1997;2409-2413
2. Eby N.L., Grufferman S., Flannelly C.M., Schold S.C., Vogel F.S., Burger P.C. Increasing evidence of primary brain lymphoma in the US. Cancer. 62:1988;2461-2465
3. Werner M.H., Phuphanich S., Lyman G.H. The increasing incidence of malignant gliomas and primary central nervous system lymphoma in the elderly. Cancer. 76:1995;1634-1642
4. Powari M., Radotra B., Das A., Banerjee A.K. A study of primary central nervous system lymphoma in northern India. Surg. Neurol. 57:2002;113-116
5. Bataille B. Traitement des lymphomes cérébraux primitifs. Principes généraux et résultats. Neurochirurgie. 43(6):1997;372-375
6. Batchelor T., Carson K., O'Neill A., Grossman S.A., Alavi J., New P., et al. Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07. J. Clin. Oncol. 21(6):2003;1044-1049
7. Hochberg F.H., Loeffler J.S., Prados M. The therapy of primary brain lymphoma. J. Neurooncol. 10:1991;191-201
8. Shibamoto Y., Tsutsui K., Dodo Y., Yamabe H., Shima N., Abe M. Improved survival rate in primary intracranial lymphoma treated by high-dose radiation and systemic vincristine-doxorubicin-cyclophosphamide-prednisolone chemotherapy. Cancer. 65:1991;1907-1912
9. Shibamoto Y., Hatabuchi N., Hiratsuka J., Tokumaru S., Shirato H., Sougawa M., et al. Is whole-brain irradiation necessary for primary central nervous system lymphoma? Patterns of recurrence after partial-brain irradiation. Cancer. 97(1):2003;128-133
10. Socié G., Piprot-Chauffat C., Schlienger M., Legars D., Thurel C., Mikol J., et al. Primary lymphoma of the central nervous system. Cancer. 65:1990;322-326
11. Algara P., Soria C., Martinez P., Sanchez L., Villuendas R., Garcia P., et al. Value of PCR detection of TCR gamma gene rearrangement in the diagnosis of cutaneous lymphocytic infiltrates. Diagn. Mol. Pathol. 3(4):1994;275-282
12. Essop M.F., Blakolmer K., Close P.M., Manuel Y.E., Cornelius S. Analysis of low and high grade B-cell lymphoma subtypes using semi-nested PCR and two primer sets. Eur. J. Haematol. 59(3):1997;136-141
13. Cheng A.L., Yeh K.H., Uen W.C., Hung R.L., Liu M.Y., Wang C.H. Systemic chemotherapy alone for patients with non-acquired immunodeficiency syndrome-related central nervous system lymphoma: a pilot study of the BOMES protocol. Cancer. 82(10):1998;1946-1951
14. De Angelis L.M., Yahalom J., Heinemann M.-H., Cirrincione C., Thaler H.T., Krol G. Primary CNS lymphoma: combined treatment with chemotherapy and radiotherapy. Neurology. 40:1990;80-86
15. Bataille B. Présentation clinique. Neurochirurgie. 43(6):1997;361-362
16. Blay J.Y., Conroy T., Chevreau C., Thyss A., Quesnel N., Eghbali H., et al. High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series. J. Clin. Oncol. 16:1998;864-871
17. Buhring U., Herrlinger U., Krings T., Thiex R., Weller M., Kuker W. MRI features of primary central nervous system lymphomas at presentation. Neurology. 57(3):2001;393-396
18. Helle T.L., Britt R.H., Colby T.V. Primary lymphoma of the central nervous system. Clinicopathological study of experience at Stanford. J. Neurosurg. 60:1984;94-103
19. Jiddane M., Nicoli F., Diaz P., Bergvall U., Vincentelli F., Hassoun J., et al. Intracranial malignant lymphoma. J. Neurosurg. 65:1986;592-599
20. Kawakami Y., Tabuchi K., Ohnishi R., Asari S., Nishimoto A. Primary central nervous system lymphoma. J. Neurosurg. 62:1985;522-527
21. Kim D.G., Nam D.H., Jung H.W., Choi K.S., Han D.H. Primary central nervous system lymphoma: variety of clinical manifestations and survival. Acta Neurochir. 138:1996;280-289
22. O'Brien P., Roos D., Pratt G., Liew K., Barton M., Poulsen M., et al. Phase II. Multicenter study of brief single-agent methotrexate followed by irradiation in primary CNS lymphoma. J. Clin. Oncol. 18:2000;519-526
23. Peterson K., Gordon K.B., Heinemann M.-H., De Angelis L.M. The clinical spectrum of ocular lymphoma. Cancer. 72:1993;843-849
24. Spaun E., Midholm S., Pedersen N.T., Ringsted J. Primary malignant lymphoma of the central nervous system. Surg. Neurol. 24:1985;646-650
25. Tomlinson F.H., Kurtin P.J., Suman V.J., Scheithauer B.W., O'Fallon J.R., Kelly P.J., et al. Primary intracerebral malignant lymphoma: a clinicopathological study of 89 patients. J. Neurosurg. 82:1995;558-566
26. Watne K., Scott H., Hager B., Lindegaard M.W., Nome O., Abrahamsen A.F., et al. Primary malignant lymphoma of the brain. Acta Oncol. 31(5):1992;545-550
27. Baumgartner J.E., Rachlin J.R., Beckstead J.H., Meeker T.C., Levy R.M., Wara W.M., et al. Primary central nervous system lymphoma: natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome. J. Neurosurg. 73:1990;206-211
28. Michalski J.M., Garcia D.M., Kase E., Grigsby P.W., Simpson J.R. Primary central nervous system lymphoma: analysis of prognostic variables and patterns of treatment failure. Radiology. 176:1990;855-860
29. Pollack I.F., Lunsford L.D., Flickinger J.C., Dameshek H.L. Prognostic factors in the diagnosis and treatment of primary central nervous system lymphoma. Cancer. 63:1989;939-947
30. Jack C.R., Reese D.F., Scheithauer B.W. Radiographic findings in 32 cases of primary CNS lymphoma. AJR. 146:1986;271-277
31. Jenkins C.N., Colquhoun I.R. Characterization of primary intracranial lymphoma by computed tomography: an analysis of 36 cases and a review of the literature with particular reference to calcification and haemorrhage and cyst formation. Clin. Radiol. 53(6):1998;428-434
32. Lee Y.-Y., Bruner J.M., Van Tassel P., Libshitz H.I. Primary central nervous system lymphoma: CT and pathologic correlation. AJNR. 147(4):1986;747-752
33. Hartmann M., Heiland S., Harting I., Tronnier V.M., Sommer C., Ludwig R., et al. Distinguishing of primary cerebral lymphoma from high-grade glioma with perfusion-weighted magnetic resonance imaging. Neurosci. Lett. 338(2):2003;119-122
34. Vandermarcq P., Drapeau C., Ferrie J.-C. Aspects par imagerie des lymphomes cérébraux primitifs. Neurochirurgie. 43(6):1997;363-368
35. Cuny E., Loiseau H., Cohadon F. Lymphomes primitifs du système nerveux central. Rôle diagnostique et pronostique des rémissions cortico-induites. Neurochirurgie. 44(1):1998;19-24
36. Tourniaire D., Pages M., Blard J.M., Pages A., Labauge R. Lymphome primitif du système nerveux central. Rémissions multiples sous corticoïdes. Rev. Neurol. (Paris). 149(3):1993;222-224
37. Vaquero J., Martinez R., Rossi E., Lopez R. Primary cerebral lymphoma: the ghost tumor. J. Neurosurg. 60:1984;174-176
38. Al-Yamany M., Lozano A., Nag S., Laperrière N., Bernstein M. Spontaneous remission of primary central nervous system lymphoma: report of 3 cases and discussion of pathophysiology. J. Neurooncol. 42(2):1999;151-159
39. Heinzlef O., Poisson M., Delattre J.Y. Régression spontanée d'un lymphome cérébral primitif. Rev. Neurol. (Paris). 152(2):1996;135-138
40. Onda K., Wakabayashi K., Tanaka R., Takahashi H. Intracranial malignant lymphomas: clinicopathological study of 26 autopsy cases. Brain Tumor Pathol. 16(1):1999;29-35
41. Bataille B., Page Ph. Facteurs pronostiques et lymphomes cérébraux primitifs. Neurochirurgie. 43(6):1997;385-387
42. Mc Allister L.D., Doolittle N.D., Guastadisegni P.E., Kraemer D.F., Lacy C.A., Crossen J.R., et al. Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma. Neurosurgery. 46:2000;51-61
43. Namiki T.S., Nichols P., Young T., Martin S.E., Chandrasoma P. Sterotaxic biopsy diagnosis of central nervous system lymphoma. Am. J. Clin. Pathol. 90(1):1988;40-45
44. Nelson D.F., Martz K.L., Bonner H., Nelson J.S., Newall J., Kerman H.D., et al. Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation therapy group (RTOG): RTOG 8315. Int. J. Radiat. Oncol. Biol. Phys. 23(1):1992;9-17
45. Sherman M.E., Erozan Y.S., Mann R.B., Kumar A.A., Mc Arthur J.C., Royal W., et al. Stereotactic brain biopsy in the diagnosis of malignant lymphoma. Am. J. Clin. Pathol. 95(6):1991;878-883
46. De Angelis L.M. Primary central nervous system lymphoma. Curr. Opin. Neurol. 12:1999;687-691
47. Delwail V., Bataille B. La chimiothérapie des lymphomes cérébraux primitifs. Neurochirurgie. 43(6):1997;380-384
48. Gabbai A.A., Hochberg F.H., Linggood R.M., Bashir R., Hotleman K. High-dose methotrexate for non-AIDS primary central nervous system lymphoma. J. Neurosurg. 70(2):1989;190-194
49. Fliessbach K., Urbach H., Helmstaedter C., Pels H., Glasmacher A., Kraus J.A., et al. Cognitive performance and magnetic resonance imaging findings after high-dose systemic and intraventricular chemotherapy for primary central nervous system lymphoma. Arch. Neurol. 60(4):2003;563-568
50. Bessel E.M., Lopez-Guillermo A., Villa S., Verger E., Nomdedeu B., Petit J., et al. Importance of radiotherapy in the outcome of patients with primary CNS lymphoma: an analysis of the CHOD/BVAM regimen followed by two different radiotherapy treatments. J. Clin. Oncol. 20:2001;231-236
51. Corn B.W., Dolinskas C., Scott C., Donahue B., Schultz C., Nelson D.F., et al. Strong correlation between imaging response and survival among patients with primary central nervous system lymphoma: a secondary analysis of RTOG studies 83-15 and 88-06. Int. J. Radiat. Oncol. Biol. Phys. 47(2):2000;299-303
52. Daban A., Bataille B. Place de la radiothérapie dans le traitement des lymphomes primitifs de l'encéphale. Présentation des résultats des séries de la SFNC et de la littérature. Neurochirurgie. 43(6):1997;376-379
53. DeAngelis L.M., Seiferheld W., Schold S.C., Fisher B., Schultz C.J. Radiation Therapy Oncology Group Study 93-10. Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: radiation Therapy Oncology Group Study 93-10A. J. Clin. Oncol. 20(24):2002;4643-4648
54. Ling S.M., Roach M., Larson D.A., Wara W.M. Radiotherapy of primary central nervous system lymphoma in patients with and without human immunodeficiency virus. Ten years of treatment experience at the University of California, San Francisco. Cancer. 73:1994;2570-2582
55. Herrlinger U., Schabet M., Brugger W., Kortmann R.D., Kanz L., Bamberg M., et al. Primary central nervous system lymphoma 1991-1997: outcome and late adverse effects after combined modality treatment. Cancer. 91(1):2001;130-135
56. Herrlinger U., Schabet M., Brugger W., Kortmann R.D., Kuker W., Deckert M., et al. German Cancer Society Neuro-Oncology Working Group NOA-03 multicenter trial of single-agent high-dose methotrexate for primary central nervous system lymphoma. Ann. Neurol. 51(2):2002;247-252
57. Neuwelt E.A., Frenkel E.P., Gumerlock M.K., Braziel R., Dana B., Hill S.A. Developments in the diagnosis and treatment of primary CNS lymphoma. A prospective series. Cancer. 58:1986;1609-1620